Related News
Home » Business » Manufacturing
Firm seals healthy purchase
Source: Agencies |
April 14, 2009, Tuesday
|
Print Edition
Print Edition
PRESCRIPTION benefits manager Express Scripts Inc said yesterday that it is buying health insurer WellPoint Inc's pharmaceutical benefit management subsidiaries for just under US$4.68 billion.
The buyout of Indianapolis-based WellPoint's NextRx subsidiaries includes a consideration for the value of a future tax benefit that St Louis-based Express Scripts might receive.
The transaction includes a 10-year contract for Express Scripts to provide services to WellPoint following closing of the transaction.
"Our aligned business model, combined with the complementary expertise and capabilities of WellPoint, creates significant opportunities for accelerated growth for both organizations," said Express Scripts Chairman and Chief Executive George Paz in a statement.
The NextRx subsidiaries provide pharmaceutical benefit management services to about 25 million Americans and manage more than 265 million prescriptions annually.
The buyout of Indianapolis-based WellPoint's NextRx subsidiaries includes a consideration for the value of a future tax benefit that St Louis-based Express Scripts might receive.
The transaction includes a 10-year contract for Express Scripts to provide services to WellPoint following closing of the transaction.
"Our aligned business model, combined with the complementary expertise and capabilities of WellPoint, creates significant opportunities for accelerated growth for both organizations," said Express Scripts Chairman and Chief Executive George Paz in a statement.
The NextRx subsidiaries provide pharmaceutical benefit management services to about 25 million Americans and manage more than 265 million prescriptions annually.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
